Clinical Trials Browser

Phase 1 × Solid Tumor × 90 days × Clear all

NCT06894745 2026-06-05

PET [89Zr]DFO-starPEG in Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06619587 2026-06-01

A Study to Evaluate Safety, Pharmacokinetics, and Activity of GDC-7035 as a Single Agent and in Combination in Patients With Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Not yet recruiting

Other solid neoplasm

Solid Tumor

NCT04381806 2026-05-22

Phase I Study in Advanced Malignancies With 5-ALA

Phase 1 Suspended

Other solid neoplasm

Solid Tumor

NCT06874335 2026-05-13

A Phase 1 Study of BHV-1530 in Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT05162755 2026-05-12

S095029 as Monotherapy and in Combination With Sym021 in Patients With Advanced Solid Tumor Malignancies Followed by an Expansion Part With Triple Combinations in Patients With Metastatic Gastric or Colorectal Cancers

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT06487858 2026-05-11

A Study of BGB-R046 as Monotherapy and in Combination With Tislelizumab in Solid Tumors

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06014502 2026-05-08

Study to Evaluate IMGS-001 Treatment in Patients With Relapsed or Refractory Advanced Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06349837 2026-05-01

Safety and Tolerability of LDRT Plus Concurrent Partial SBRT and Tislelizumab in Patients With Bulky Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT07554196 2026-04-28

A Phase 1 Clinical Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of HH-101 in Patients With Advanced Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor

NCT05430360 2026-04-27

GT201

Phase 1 Terminated

Other solid neoplasm

Solid Tumor

NCT06132828 2026-04-27

Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06297525 2026-04-23

Study of STP938 in Advanced Solid Tumours

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06576037 2026-04-16

Phase Ib Study of CBP-1019 in Combination With FOLFOX +/- Bevacizumab, Pembrolizumab, or Enzalutamide for Metastatic TRPV6-overexpressing Solid Tumors of Epithelial Origin

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT06718621 2026-04-14

A Study of BL-M08D1 in Patients With Locally Advanced or Metastatic Solid Tumors

Phase 1 Recruiting

Other solid neoplasm

Solid Tumor

NCT04158336 2026-03-18

A Study of Azenosertib (ZN-c3) in Participants With Solid Tumors

Phase 1 Completed

Other solid neoplasm

Solid Tumor